Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation
Viruses · 2024
DOI: 10.3390/v16111765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Shuwen Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Agricultural Science and Engineering, Liaocheng University, Liaocheng 252000, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Benzylisoquinolines, Antiviral Agents, Herpesviridae Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Shandong Province Higher Educational Science and Technology Program for Youth, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Equid herpesvirus type 8 (EqHV-8) is known to cause respiratory disease and miscarriage in horses and donkeys, which is a major problem for the equine farming industry. However, there are currently limited vaccines or drugs available to effectively treat EqHV-8 infection. Therefore, it is crucial to develop new antiviral approaches to prevent potential pandemics caused by EqHV-8. This study evaluates the antiviral and antioxidant effects of cepharanthine against EqHV-8 by employing both in vitro assays and in vivo mouse models to assess its therapeutic efficacy. To assess the effectiveness of cepharanthine against EqHV-8, we conducted experiments using NBL-6 and RK-13 cells. Additionally, we developed a mouse model to validate cepharanthine’s effectiveness against EqHV-8. In our in vitro experiments, we assessed the cepharanthine’s ability to inhibit infection caused by EqHV-8 in NBL-6 and RK-13 cells. Our results demonstrated that cepharanthine has a dose-dependent inhibitory effect, indicating that it possesses anti-EqHV-8 properties at the cellular level. Moreover, we investigated the mechanism through which cepharanthine exerts its protective effects. It was observed that cepharanthine effectively reduces the oxidative stress induced by EqHV-8 by activating the AMPK and Nrf2/HO-1 signaling pathways. Furthermore, when administered to EqHV-8 infected mice, cepharanthine significantly improved lung tissue pathology and reduced oxidative stress. The findings presented herein collectively highlight cepharanthine as a promising candidate for combating EqHV-8 infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Agricultural Science and Engineering, Liaocheng University, Liaocheng 252000, China.
- College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Jinzhong 030801, China.
ORCID-Profile: Liangliang Li, Muhammad Zahoor Khan
Förderung
- National Key R&D Program of China
- Shandong Province Higher Educational Science and Technology Program for Youth
- Natural Science Foundation of Shandong Province
- Innovation and Entrepreneurship Program for College Students
- National Natural Science Foundation of China
- Open Project of Liaocheng University Animal Husbandry Discipline
- National Key R&D Program of China
- Shandong Province Modern Agricultural Technology System Donkey Industrial Innovation Team
Zitieren
APA
Li, S., Li, L., Sun, Y., Khan, M. Z., Yu, Y., Ruan, L., Chen, L., Zhao, J., Jia, J., Li, Y., Wang, C., & Wang, T. (2024). Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation. Viruses. https://doi.org/10.3390/v16111765
Vancouver
Li S, Li L, Sun Y, Khan MZ, Yu Y, Ruan L, et al. Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation. Viruses. 2024. doi:10.3390/v16111765
BibTeX
@article{Li2024,
author = {Li, Shuwen and Li, Liangliang and Sun, Yijia and Khan, Muhammad Zahoor and Yu, Yue and Ruan, Lian and Chen, Li and Zhao, Juan and Jia, Junchi and Li, Yubao and Wang, Changfa and Wang, Tongtong},
title = {Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16111765}
}
EUVIMED